|
GABPB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.23899999999677E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.69510000000273E-05 |
| Normal-vs-Stage2 |
1.809570E-02 |
| Normal-vs-Stage3 |
3.908100E-02 |
| Normal-vs-Stage4 |
1.941290E-03 |
| Stage1-vs-Stage2 |
9.090400E-01 |
| Stage1-vs-Stage3 |
9.122300E-02 |
| Stage1-vs-Stage4 |
6.723800E-01 |
| Stage2-vs-Stage3 |
3.317000E-01 |
| Stage2-vs-Stage4 |
7.022400E-01 |
| Stage3-vs-Stage4 |
1.333610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.88910000000254E-05 |
| Normal-vs-AfricanAmerican |
3.984200E-02 |
| Normal-vs-Asian |
1.002030E-02 |
| Caucasian-vs-AfricanAmerican |
4.948000E-01 |
| Caucasian-vs-Asian |
3.760200E-01 |
| AfricanAmerican-vs-Asian |
2.289800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.182100E-04 |
| Normal-vs-Female |
2.42429999999239E-05 |
| Male-vs-Female |
1.275770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.529600E-02 |
| Normal-vs-Age(41-60Yrs) |
7.78880000000814E-05 |
| Normal-vs-Age(61-80Yrs) |
4.581100E-04 |
| Normal-vs-Age(81-100Yrs) |
6.658400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.081000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.983000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.492180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.212600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.139370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.472250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.331560E-02 |
| Normal-vs-Grade 2 |
3.22310000000492E-06 |
| Normal-vs-Grade 3 |
2.113700E-02 |
| Normal-vs-Grade 4 |
1.795560E-02 |
| Grade 1-vs-Grade 2 |
2.772200E-01 |
| Grade 1-vs-Grade 3 |
1.830030E-02 |
| Grade 1-vs-Grade 4 |
1.628970E-01 |
| Grade 2-vs-Grade 3 |
4.081200E-03 |
| Grade 2-vs-Grade 4 |
3.223000E-01 |
| Grade 3-vs-Grade 4 |
3.768400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.95999000000002E-05 |
| Normal-vs-ccB subtype |
9.367000E-04 |
| ccA subtype-vs-ccB subtype |
3.758600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.4029000000021E-05 |
| Normal-vs-N1 |
1.710820E-01 |
| N0-vs-N1 |
9.064800E-01 |
|
|
